A new easy-to-synthesize solid supported Eosin Y and its application in the building of a catalytic continuous flow reactor is reported. The fluidic device was employed to perform tertiary amines in-flow photooxidations followed by a…
Discovering the World of Chemistry
Discovery chemistry, custom synthesis and process development from lab to kg-/pilot scale for global pharmaceutical, biotech and chemical companies since 1999.
Home » Home
Latest News
Read more
The 20th Annual event brings back popular topics like PROTACs and RNA plus new programming on immunomodulation, antivirals, neurodegeneration targets, KRAS, and AI.
ChemOutsourcing is the largest USA-based API and Pharmaceutical Ingredients Sept show attracting annually 700-800 customers, project and executive management…
The 2022 programme will cover advances in drug discovery in major therapeutic areas, including bacterial and viral infections, with a particular attention to current and emerging viral pandemics, but also neurodegenerative and cardiovascular diseases, rare diseases and cancer…
Discovery Chemistry services to materialize your ideas
At Taros we regularly perform contract research with an emphasis on the design and synthesis of novel building blocks, intermediates and final compounds for several applications. We pride ourselves on a 20 year track record of success in supporting diverse industries with their chemistry and innovation challenges. Our scientists specialize in organic and organometallic synthesis including polymers, from lab scale to pilot quantities. Taros operates a customer-centric and flexible business model providing our diverse clients with customized innovative discovery chemistry services:
We provide long-term added value to our diverse customers through discovery chemistry services and contract research
Our contract research focuses on holistic and cost-effective solutions of the highest quality for the global marketplace. We are inspired to provide exceptional added value to our customers’ R&D processes by anticipating hurdles foreseeing cost and lead time reductions. Thereby we facilitate competitive and “early-to-market” advantages. With our state-of-the-art lab facilities and our scientists (of which 65% hold a Ph.D. in Chemistry), we are committed to serve the diverse needs of our customers with discovery chemistry services in drug discovery, custom synthesis and specialty or performance chemicals. More than 13,000 synthesis, research and process chemistry projects have been delivered successfully to our ever-growing global customer base.
Taros Chemicals GmbH & Co. KG receives funding from the program European Regional Development Fund (ERDF / EFRE) by the state of North Rhine-Westphalia and the Europen Union.
